Quanterix Corporation

NASDAQ:QTRX

Medical - Devices

Healthcare
$2.07 +15.80%

+$0.46 today

Market cap
$98.28M
Beta
1.12
P/E (TTM)
-1.5
EPS (TTM)
-$2.22
52W Low $2.40High $8.77

Volume 3.54M

Average 1.15M

QTRX Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

Quanterix CorporationNASDAQ: QTRX

Gross Margin · Q1 FY2026 · quarter ended Mar 2026

Gross margin narrows to 42.7%

Gross margin was 42.7% in Q1 FY2026, down 11.3 pp from a year earlier. On a trailing-twelve-month basis it was 44.1%, down 15.0 pp year over year. Over 3 fiscal years it widened by 3.7 pp.

Context

  • Gross margin widened in 1 of the last 3 fiscal years.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
42.7%-2.8 pp QoQ
Last fiscal yearDec 2025
46.7%-13.2 pp YoY
LTMMar 2026
44.1%-15.0 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-11.3 pp——
1 year-13.2 pp——
3 years+3.7 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
46.7%
Year-over-year change
-13.2pp

Gross Margin vs competitors

How QTRX compares with its peers on the latest reported figures

  • QTRX's LTM Mar 2026 gross margin of 44.1% is the 8th highest of the 10 companies compared; the peer median is 52.1%.
  • Its year-over-year change of -15.0 pp is the lowest of 10, against a peer median of +0.5 pp.
  • Over three fiscal years its change of +3.7 pp compares with a peer median of +3.5 pp.
QTRX Competitors Peer median
Gross Margin for QTRX and competitors
Company Period LTM level YoY 3-year change
SGHTSight Sciences, Inc.LTM Mar 202686.2% +0.5 pp+3.5 pp
CVRXCVRx, Inc.LTM Mar 202685.5% +1.8 pp+7.6 pp
SNWVSANUWAVE Health, Inc.LTM Mar 202675.7% -0.9 pp+3.0 pp
VMDViemed Healthcare, Inc.LTM Mar 202657.3% -1.4 pp-3.5 pp
SENSSenseonics Holdings, Inc.LTM Mar 202652.1% +44.9 pp+28.1 pp
MASS908 Devices Inc.LTM Mar 202649.0% -1.6 pp-7.9 pp
INGNInogen, Inc.LTM Mar 202648.7% +2.6 pp+6.9 pp
QTRXQuanterix CorporationLTM Mar 202644.1% -15.0 pp+3.7 pp
OMOutset Medical, Inc.LTM Mar 202640.6% +4.7 pp+23.7 pp
NNOXNano-X Imaging Ltd.LTM Dec 2025-98.2% -3.3 pp-18.0 pp
IMRXImmuneering CorporationFY2025— ——
Peer median (excluding QTRX) 52.1%+0.5 pp+3.5 pp

Competitors are the stored peer set for QTRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue110.56M105.52M121.14M135.44M138.65M
Cost of Revenue45.78M60.16M48.14M54.32M73.94M
Gross Profit64.77M45.36M73M81.12M64.72M
Gross Margin58.6%43.0%60.3%59.9%46.7%
Research & Development28.38M26.81M26.06M31.08M35.92M
Selling, General & Admin92.91M91.85M92.82M104.64M138.85M
Operating Expenses121.29M149.63M118.99M133.74M174.53M
Depreciation & Amortization4.88M5.41M8.29M8.36M18.93M
EBITDA(50.3M)(67.89M)(36.37M)(29.74M)(93.35M)
EBITDA Margin-45.5%-64.3%-30.0%-22.0%-67.3%
Operating Income(56.52M)(104.26M)(45.99M)(52.62M)(109.82M)
Operating Margin-51.1%-98.8%-38.0%-38.8%-79.2%
Interest Income05.13M15.84M14.66M8.57M
Interest Expense403K0000
Other Income / Expenses937K4.85M18.36M14.52M(2.46M)
Income Before Tax(55.58M)(99.41M)(27.64M)(38.1M)(112.27M)
Pre-Tax Margin-50.3%-94.2%-22.8%-28.1%-81.0%
Income Tax Expense(36K)164K719K434K(5.12M)
Net Income(55.55M)(99.57M)(28.35M)(38.53M)(107.15M)
Net Margin-50.2%-94.4%-23.4%-28.4%-77.3%
EPS (Basic)(1.60)(2.61)(0.86)(1.00)(2.51)
EPS (Diluted)(1.60)(2.61)(0.86)(1.00)(2.51)
Weighted Avg Shares36M36.99M37.59M38.37M42.64M
Weighted Avg Shares (Diluted)36M36.99M37.59M38.37M42.64M

Quanterix Corporation

NASDAQ:QTRX

Intrinsic Alpha fair value

Locked

Current Price

$2.07

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.